BioCentury
ARTICLE | Clinical News

PecFent regulatory update

September 6, 2010 7:00 AM UTC

The European Commission approved an MAA from Archimedes for PecFent fentanyl nasal spray to treat breakthrough cancer pain. The company plans to launch PecFent, which uses the PecSys nasal spray drug ...